haloperidol has been researched along with fluorodeoxyglucose f18 in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (46.15) | 18.2507 |
| 2000's | 6 (46.15) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buchsbaum, MS; Gottschalk, LA; Gulasekaram, B; Katz, M; Lohr, J; Lottenberg, S; Marshall, JF; Potkin, SG; Siegel, BV; Teng, CY | 1 |
| Bartlett, EJ; Brodie, JD; Dewey, SL; Fowler, JS; Rusinek, H; Simkowitz, P; Smith, G; Volkow, ND; Wolf, AP; Wolkin, A | 1 |
| Cascella, NG; Dannals, RF; Holcomb, HH; Medoff, DR; Tamminga, CA; Thaker, GK | 1 |
| Bartlett, EJ; Brodie, JD; Cancro, R; Dewey, SL; Rusinek, H; Simkowitz, P; Smith, G; Volkow, ND; Wolf, AP; Wolkin, A | 1 |
| Conley, RR; Tamminga, CA | 1 |
| Bartlett, EJ; Brodie, JD; Cancro, R; Dewey, SL; Lindenmayer, JP; Rusinek, H; Schiffer, W; Schlösser, R; Simkowitz, P; Wolkin, A | 1 |
| Holcomb, H; Tamminga, C | 1 |
| Benito, C; Desco, M; Gispert, JD; Molina, V; Palomo, T; Pascau, J; Reig, S; Santos, A; Sanz, J; Sarramea, F | 1 |
| Fujibayashi, Y; Igarashi, K; Kasuya, F; Maruoka, N; Murata, T; Omata, N; Takashima, Y; Wada, Y | 1 |
| Aronowitz, J; Bloom, R; Brand, J; Brickman, AM; Buchsbaum, MS; Goldstein, KE; Hazlett, EA; Haznedar, MM; Heath, D; Newmark, RE; Starson, M | 1 |
| Bartenstein, P; Buchholz, HG; Cumming, P; Gründer, G; Hilgers, RD; Kumakura, Y; Siessmeier, T; Vernaleken, I | 1 |
| Buchsbaum, MS; Chu, KW; Dusi, N; Entis, JJ; Goldstein, KE; Goodman, CR; Gupta, A; Hazlett, E; Haznedar, M; Iannuzzi, J; Newmark, RE; Torosjan, Y; Wolkin, A; Zhang, J | 1 |
| Alessandrini, F; Avesani, M; Bertolasi, L; Bovi, P; Buffone, CE; Moretto, G; Musso, A; Ottaviani, S; Passarin, MG; Petrilli, G; Romito, S; Santini, F | 1 |
1 review(s) available for haloperidol and fluorodeoxyglucose f18
| Article | Year |
|---|---|
The application of neuroimaging techniques to drug development.
Topics: Antipsychotic Agents; Brain; Brain Chemistry; Carbon Radioisotopes; Cerebrovascular Circulation; Deoxyglucose; Diagnostic Imaging; Drug Industry; Drugs, Investigational; Fluorodeoxyglucose F18; Haloperidol; Humans; Ketamine; Magnetic Resonance Imaging; Mental Disorders; Neuropharmacology; Receptors, Dopamine; Spiperone; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 1997 |
2 trial(s) available for haloperidol and fluorodeoxyglucose f18
| Article | Year |
|---|---|
Striatal metabolic rate and clinical response to neuroleptics in schizophrenia.
Topics: Adult; Basal Ganglia; Caudate Nucleus; Cerebral Cortex; Deoxyglucose; Double-Blind Method; Female; Fluorodeoxyglucose F18; Glucose; Haloperidol; Humans; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Putamen; Receptors, Dopamine; Schizophrenia; Schizophrenic Psychology; Tomography, Emission-Computed | 1992 |
FDG-PET and MRI imaging of the effects of sertindole and haloperidol in the prefrontal lobe in schizophrenia.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Brain Mapping; Female; Fluorodeoxyglucose F18; Frontal Lobe; Haloperidol; Humans; Imidazoles; Indoles; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Psychiatric Status Rating Scales; Schizophrenia; Young Adult | 2009 |
10 other study(ies) available for haloperidol and fluorodeoxyglucose f18
| Article | Year |
|---|---|
Effects of haloperidol challenge on regional cerebral glucose utilization in normal human subjects.
Topics: Adult; Brain; Cerebellum; Cerebral Cortex; Deoxyglucose; Fluorodeoxyglucose F18; Glucose; Haloperidol; Humans; Limbic System; Male; Mental Disorders; Putamen; Thalamus; Tomography, Emission-Computed | 1994 |
Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol.
Topics: Adult; Age of Onset; Basal Ganglia; Brain; Cerebral Cortex; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Haloperidol; Humans; Limbic System; Magnetic Resonance Imaging; Male; Middle Aged; Psychiatric Status Rating Scales; Receptors, Dopamine; Schizophrenia; Schizophrenic Psychology; Thalamus; Tomography, Emission-Computed | 1996 |
Time-dependent effects of a haloperidol challenge on energy metabolism in the normal human brain.
Topics: Adult; Antipsychotic Agents; Blood Glucose; Brain; Deoxyglucose; Energy Metabolism; Extrapyramidal Tracts; Fluorodeoxyglucose F18; Haloperidol; Humans; Injections, Intramuscular; Male; Neurologic Examination; Receptors, Dopamine; Receptors, Dopamine D2; Reference Values; Tomography, Emission-Computed | 1996 |
Effect of a haloperidol challenge on regional brain metabolism in neuroleptic-responsive and nonresponsive schizophrenic patients.
Topics: Adult; Algorithms; Antipsychotic Agents; Brain; Brief Psychiatric Rating Scale; Cerebellum; Corpus Striatum; Dose-Response Relationship, Drug; Female; Fluorodeoxyglucose F18; Glucose; Haloperidol; Humans; Magnetic Resonance Imaging; Male; Neocortex; Receptors, Dopamine D2; Schizophrenia; Severity of Illness Index; Tomography, Emission-Computed; Treatment Outcome | 1998 |
Neural networks: neural systems vi: basal ganglia.
Topics: Basal Ganglia; Fluorodeoxyglucose F18; Haloperidol; Humans; Neural Pathways; Regional Blood Flow; Tomography, Emission-Computed | 2001 |
Cerebral metabolic patterns in chronic and recent-onset schizophrenia.
Topics: Acute Disease; Adult; Basal Ganglia; Brain; Brain Mapping; Cerebellum; Cerebral Cortex; Chronic Disease; Energy Metabolism; Female; Fluorodeoxyglucose F18; Frontal Lobe; Haloperidol; Humans; Long-Term Care; Male; Middle Aged; Motor Cortex; Schizophrenia; Schizophrenia, Paranoid; Tomography, Emission-Computed; Visual Cortex | 2003 |
Effects of haloperidol and its pyridinium metabolite on plasma membrane permeability and fluidity in the rat brain.
Topics: Animals; Anisotropy; Autoradiography; Brain; Brain Mapping; Cell Membrane; Cell Membrane Permeability; Fluorodeoxyglucose F18; Haloperidol; In Vitro Techniques; L-Lactate Dehydrogenase; Male; Pyridinium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Wistar; Statistics, Nonparametric; Thiobarbituric Acid Reactive Substances; Time Factors | 2007 |
FDG-PET in never-previously medicated psychotic adolescents treated with olanzapine or haloperidol.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Brain; Cognition Disorders; Female; Fluorodeoxyglucose F18; Frontal Lobe; Haloperidol; Humans; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Occipital Lobe; Olanzapine; Positron-Emission Tomography; Psychotic Disorders; Radiopharmaceuticals; Temporal Lobe | 2007 |
Baseline [18F]-FDOPA kinetics are predictive of haloperidol-induced changes in dopamine turnover and cognitive performance: A positron emission tomography study in healthy subjects.
Topics: Adult; Algorithms; Brain; Brain Chemistry; Cognition; Data Interpretation, Statistical; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Female; Fluorodeoxyglucose F18; Haloperidol; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Predictive Value of Tests; Psychomotor Performance; Radiopharmaceuticals; Receptors, Dopamine D3 | 2008 |
Late-onset choreoathetotic syndrome following heart surgery.
Topics: Age of Onset; Anti-Dyskinesia Agents; Basal Ganglia; Brain Diseases; Cardiac Surgical Procedures; Chorea; Female; Fluorodeoxyglucose F18; Haloperidol; Humans; Middle Aged; Positron-Emission Tomography; Syndrome; Time Factors; Treatment Outcome | 2010 |